Work

A Phase 1/2 Study of Weekly MLN9708, an Investigational Oral Proteasome Inhibitor, in Combination with Lenalidomide and Dexamethasone in Patients with Previously Untreated Multiple Myeloma (MM)

Year: 2012

Type: article

Study design: Clinical Trial

Source: Blood

DOI: 10.1182/blood.v120.21.332.332

Authors: Shaji K. Kumar, Jesus G. Berdeja, Ruben Niesvizky, Sagar Lonial, Mehdi Hamadani, A. Keith Stewart, Vivek Roy, Parameswaran Hari, Robert Vescio, Deborah Berg, Jianchang Lin, Alessandra Di Bacco, Neeraj Gupta, Ai-Min Hui, Paul G. Richardson

Institutions: Mayo Clinic, Sarah Cannon, NewYork–Presbyterian Hospital, Cornell University, Winship Cancer Institute, West Virginia University, Mayo Clinic in Arizona, Mayo Clinic in Florida, Medical College of Wisconsin, Cedars-Sinai Medical Center, Takeda Oncology (United States), Dana-Farber Cancer Institute

Language: English

Topic: Multiple Myeloma Research and Treatments

Subfield: Hematology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4229767151

FWCI: 3.654

Cites:

Cited by: 20

Related to: 10